{"transactions":[{"id":3039575,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-03T19:01:26.000Z","date":"2020-09-01","kind":"exercise","acquired":false,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the 472,223 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022."}],"balance_after":443389,"derivative":{"exercise_price":10.8,"expiration_date":"2028-09-27","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001562180-20-005870","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020005870/primarydocument.xml","form_type":"4"}},{"id":3039574,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-09-03T19:01:26.000Z","date":"2020-09-01","kind":"sale","acquired":false,"shares":13410,"price":32.06,"value":429924.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $31.89 to $32.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3)."}],"balance_after":164484,"source":{"system":"sec-edgar","filing":"0001562180-20-005870","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020005870/primarydocument.xml","form_type":"4"}},{"id":3039573,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-09-03T19:01:26.000Z","date":"2020-09-01","kind":"sale","acquired":false,"shares":14090,"price":31.29,"value":440876.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $30.86 to $31.85, inclusive."}],"balance_after":177894,"source":{"system":"sec-edgar","filing":"0001562180-20-005870","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020005870/primarydocument.xml","form_type":"4"}},{"id":3039572,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-09-03T19:01:26.000Z","date":"2020-09-01","kind":"exercise","acquired":true,"shares":27500,"price":10.8,"value":297000.0,"ownership":{"direct":true},"balance_after":191984,"source":{"system":"sec-edgar","filing":"0001562180-20-005870","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020005870/primarydocument.xml","form_type":"4"}},{"id":3067734,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-05T19:09:56.000Z","date":"2020-08-03","kind":"exercise","acquired":false,"shares":26166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the 163,666 shares underlying the options vested in an annual installment and the remaining balance vested in equal monthly installments until the option vested in full on Oct. 28, 2019."}],"balance_after":0,"derivative":{"exercise_price":10.3,"exercise_date":"2019-10-28","expiration_date":"2025-11-09","underlying":"Common Stock","underlying_shares":26166},"source":{"system":"sec-edgar","filing":"0001562180-20-005339","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020005339/primarydocument.xml","form_type":"4"}},{"id":3067733,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-05T19:09:56.000Z","date":"2020-08-03","kind":"exercise","acquired":false,"shares":1334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the 472,223 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022."}],"balance_after":470889,"derivative":{"exercise_price":10.8,"expiration_date":"2028-09-27","underlying":"Common Stock","underlying_shares":1334},"source":{"system":"sec-edgar","filing":"0001562180-20-005339","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020005339/primarydocument.xml","form_type":"4"}},{"id":3067732,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-08-05T19:09:56.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":17870,"price":35.7,"value":637959.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $35.43 to $35.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3)."}],"balance_after":164484,"source":{"system":"sec-edgar","filing":"0001562180-20-005339","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020005339/primarydocument.xml","form_type":"4"}},{"id":3067731,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-08-05T19:09:56.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":1334,"price":35.19,"value":46943.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $34.42 to $35.41, inclusive."}],"balance_after":182354,"source":{"system":"sec-edgar","filing":"0001562180-20-005339","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020005339/primarydocument.xml","form_type":"4"}},{"id":3067730,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-08-05T19:09:56.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":8296,"price":35.19,"value":291936.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $34.42 to $35.41, inclusive."}],"balance_after":183688,"source":{"system":"sec-edgar","filing":"0001562180-20-005339","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020005339/primarydocument.xml","form_type":"4"}},{"id":3067729,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-08-05T19:09:56.000Z","date":"2020-08-03","kind":"exercise","acquired":true,"shares":8296,"price":10.3,"value":85448.8,"ownership":{"direct":true},"balance_after":191984,"source":{"system":"sec-edgar","filing":"0001562180-20-005339","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020005339/primarydocument.xml","form_type":"4"}},{"id":3067728,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-08-05T19:09:56.000Z","date":"2020-08-03","kind":"exercise","acquired":true,"shares":17870,"price":10.3,"value":184061.0,"ownership":{"direct":true},"balance_after":183688,"source":{"system":"sec-edgar","filing":"0001562180-20-005339","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020005339/primarydocument.xml","form_type":"4"}},{"id":3067727,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-08-05T19:09:56.000Z","date":"2020-08-03","kind":"exercise","acquired":true,"shares":1334,"price":10.8,"value":14407.2,"ownership":{"direct":true},"balance_after":165818,"source":{"system":"sec-edgar","filing":"0001562180-20-005339","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020005339/primarydocument.xml","form_type":"4"}},{"id":3089085,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-06T17:50:12.000Z","date":"2020-07-01","kind":"exercise","acquired":false,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the 163,666 shares underlying the options vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on Oct. 28, 2019."}],"balance_after":26166,"derivative":{"exercise_price":10.3,"exercise_date":"2019-10-28","expiration_date":"2025-11-09","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001562180-20-005000","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020005000/primarydocument.xml","form_type":"4"}},{"id":3089084,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-07-06T17:50:12.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":2800,"price":29.79,"value":83412.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $29.55 to $30.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3)."}],"balance_after":164484,"source":{"system":"sec-edgar","filing":"0001562180-20-005000","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020005000/primarydocument.xml","form_type":"4"}},{"id":3089083,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-07-06T17:50:12.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":24700,"price":28.82,"value":711854.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $28.53 to $29.43, inclusive."}],"balance_after":167284,"source":{"system":"sec-edgar","filing":"0001562180-20-005000","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020005000/primarydocument.xml","form_type":"4"}},{"id":3089082,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-07-06T17:50:12.000Z","date":"2020-07-01","kind":"exercise","acquired":true,"shares":27500,"price":10.3,"value":283250.0,"ownership":{"direct":true},"balance_after":191984,"source":{"system":"sec-edgar","filing":"0001562180-20-005000","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020005000/primarydocument.xml","form_type":"4"}},{"id":3100983,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-24T17:18:38.000Z","date":"2020-06-22","kind":"exercise","acquired":false,"shares":9259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests based on the satisfaction of both a time-based vesting condition and a liquidity-based vesting condition. The time-based vesting condition is satisfied as follows: 25% of the shares subject to the stock option satisfied the time-based vesting condition on September 25, 2019 and the remaining 75% will satisfy the time-based vesting condition in 36 equal monthly installments thereafter, generally subject to the Reporting Person's continuous service relationship with the Company through each applicable vesting date. The liquidity-based vesting condition was satisfied upon the Company's initial public offering."}],"balance_after":490741,"derivative":{"exercise_price":10.8,"expiration_date":"2028-09-27","underlying":"Common Stock","underlying_shares":9259},"source":{"system":"sec-edgar","filing":"0001562180-20-004676","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020004676/primarydocument.xml","form_type":"4"}},{"id":3100982,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-24T17:18:38.000Z","date":"2020-06-22","kind":"exercise","acquired":false,"shares":6313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests based on the satisfaction of both a time-based vesting condition and a liquidity-based vesting condition. The time-based vesting condition is satisfied as follows: 25% of the shares subject to the stock option satisfied the time-based vesting condition on February 5, 2020 and the remaining 75% will satisfy the time-based vesting condition in 36 equal monthly installments thereafter, generally subject to the Reporting Person's continuous service relationship with the Company through each applicable vesting date. The liquidity-based vesting condition was satisfied upon the Company's initial public offering."}],"balance_after":293687,"derivative":{"exercise_price":15.84,"expiration_date":"2029-02-05","underlying":"Common Stock","underlying_shares":6313},"source":{"system":"sec-edgar","filing":"0001562180-20-004676","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020004676/primarydocument.xml","form_type":"4"}},{"id":3100981,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-06-24T17:18:38.000Z","date":"2020-06-22","kind":"exercise","acquired":true,"shares":9259,"price":10.8,"value":99997.2,"ownership":{"direct":true},"balance_after":164484,"source":{"system":"sec-edgar","filing":"0001562180-20-004676","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020004676/primarydocument.xml","form_type":"4"}},{"id":3100980,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-06-24T17:18:38.000Z","date":"2020-06-22","kind":"exercise","acquired":true,"shares":6313,"price":15.84,"value":99997.92,"ownership":{"direct":true},"balance_after":155225,"source":{"system":"sec-edgar","filing":"0001562180-20-004676","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020004676/primarydocument.xml","form_type":"4"}},{"id":3124601,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-03T16:47:16.000Z","date":"2020-06-01","kind":"exercise","acquired":false,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the 163,666 shares underlying the options vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on Oct. 28, 2019"}],"balance_after":53666,"derivative":{"exercise_price":10.3,"exercise_date":"2019-10-28","expiration_date":"2025-11-09","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001562180-20-004169","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020004169/primarydocument.xml","form_type":"4"}},{"id":3124600,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-06-03T16:47:16.000Z","date":"2020-06-01","kind":"sale","acquired":false,"shares":27500,"price":26.97,"value":741675.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $26.63 to $27.49, inclusive."}],"balance_after":148912,"source":{"system":"sec-edgar","filing":"0001562180-20-004169","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020004169/primarydocument.xml","form_type":"4"}},{"id":3124599,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-06-03T16:47:16.000Z","date":"2020-06-01","kind":"exercise","acquired":true,"shares":27500,"price":10.3,"value":283250.0,"ownership":{"direct":true},"balance_after":176412,"source":{"system":"sec-edgar","filing":"0001562180-20-004169","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020004169/primarydocument.xml","form_type":"4"}},{"id":3161454,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-05T19:26:41.000Z","date":"2020-05-01","kind":"exercise","acquired":false,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the 163,666 shares underlying the options vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on Oct. 28, 2019."}],"balance_after":81166,"derivative":{"exercise_price":10.3,"exercise_date":"2019-10-28","expiration_date":"2025-11-09","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001562180-20-003394","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020003394/primarydocument.xml","form_type":"4"}},{"id":3161453,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-05-05T19:26:41.000Z","date":"2020-05-01","kind":"sale","acquired":false,"shares":27500,"price":25.37,"value":697675.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1."}],"balance_after":148912,"source":{"system":"sec-edgar","filing":"0001562180-20-003394","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020003394/primarydocument.xml","form_type":"4"}},{"id":3161452,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-05-05T19:26:41.000Z","date":"2020-05-01","kind":"exercise","acquired":true,"shares":27500,"price":10.3,"value":283250.0,"ownership":{"direct":true},"balance_after":176412,"source":{"system":"sec-edgar","filing":"0001562180-20-003394","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020003394/primarydocument.xml","form_type":"4"}},{"id":3167509,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-29T20:09:40.000Z","date":"2020-04-28","kind":"exercise","acquired":false,"shares":48850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the 50,000 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on Nov. 1, 2015."}],"balance_after":0,"derivative":{"exercise_price":2.46,"exercise_date":"2015-11-01","expiration_date":"2022-01-03","underlying":"Common Stock","underlying_shares":48850},"source":{"system":"sec-edgar","filing":"0001562180-20-003209","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020003209/primarydocument.xml","form_type":"4"}},{"id":3167508,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-29T20:09:40.000Z","date":"2020-04-28","kind":"exercise","acquired":false,"shares":38834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the 38,384 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on Mar. 28, 2019."}],"balance_after":0,"derivative":{"exercise_price":10.3,"exercise_date":"2019-03-28","expiration_date":"2025-11-09","underlying":"Common Stock","underlying_shares":38834},"source":{"system":"sec-edgar","filing":"0001562180-20-003209","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020003209/primarydocument.xml","form_type":"4"}},{"id":3167507,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-04-29T20:09:40.000Z","date":"2020-04-28","kind":"exercise","acquired":true,"shares":48850,"price":2.46,"value":120171.0,"ownership":{"direct":true},"balance_after":148912,"source":{"system":"sec-edgar","filing":"0001562180-20-003209","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020003209/primarydocument.xml","form_type":"4"}},{"id":3167506,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-04-29T20:09:40.000Z","date":"2020-04-28","kind":"exercise","acquired":true,"shares":38834,"price":10.3,"value":399990.2,"ownership":{"direct":true},"balance_after":100062,"source":{"system":"sec-edgar","filing":"0001562180-20-003209","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020003209/primarydocument.xml","form_type":"4"}},{"id":3183852,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-03T17:52:28.000Z","date":"2020-04-01","kind":"exercise","acquired":false,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the 163,666 shares underlying the options vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on Oct. 28, 2019."}],"balance_after":108666,"derivative":{"exercise_price":10.3,"exercise_date":"2019-10-28","expiration_date":"2025-11-09","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001562180-20-002899","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020002899/primarydocument.xml","form_type":"4"}},{"id":3183851,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-04-03T17:52:28.000Z","date":"2020-04-01","kind":"sale","acquired":false,"shares":7878,"price":26.03,"value":205064.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $26.00 to $26.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3)."}],"balance_after":61228,"source":{"system":"sec-edgar","filing":"0001562180-20-002899","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020002899/primarydocument.xml","form_type":"4"}},{"id":3183850,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-04-03T17:52:28.000Z","date":"2020-04-01","kind":"sale","acquired":false,"shares":19622,"price":25.56,"value":501538.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $25.00 to $25.99, inclusive."}],"balance_after":69106,"source":{"system":"sec-edgar","filing":"0001562180-20-002899","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020002899/primarydocument.xml","form_type":"4"}},{"id":3183849,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-04-03T17:52:28.000Z","date":"2020-04-01","kind":"exercise","acquired":true,"shares":27500,"price":10.3,"value":283250.0,"ownership":{"direct":true},"balance_after":88728,"source":{"system":"sec-edgar","filing":"0001562180-20-002899","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020002899/primarydocument.xml","form_type":"4"}},{"id":3224736,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-05T19:37:31.000Z","date":"2020-03-03","kind":"exercise","acquired":false,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the 163,666 shares underlying the options vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on Oct. 28, 2019."}],"balance_after":136166,"derivative":{"exercise_price":10.3,"exercise_date":"2019-10-28","expiration_date":"2025-11-09","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001562180-20-002257","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020002257/primarydocument.xml","form_type":"4"}},{"id":3224735,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-03-05T19:37:31.000Z","date":"2020-03-03","kind":"sale","acquired":false,"shares":3900,"price":29.33,"value":114387.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $28.97 to $29.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3)."}],"balance_after":61228,"source":{"system":"sec-edgar","filing":"0001562180-20-002257","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020002257/primarydocument.xml","form_type":"4"}},{"id":3224734,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-03-05T19:37:31.000Z","date":"2020-03-03","kind":"sale","acquired":false,"shares":23600,"price":28.32,"value":668352.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $27.96 to $28.88, inclusive."}],"balance_after":65128,"source":{"system":"sec-edgar","filing":"0001562180-20-002257","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020002257/primarydocument.xml","form_type":"4"}},{"id":3224733,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-03-05T19:37:31.000Z","date":"2020-03-03","kind":"exercise","acquired":true,"shares":27500,"price":10.3,"value":283250.0,"ownership":{"direct":true},"balance_after":88728,"source":{"system":"sec-edgar","filing":"0001562180-20-002257","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020002257/primarydocument.xml","form_type":"4"}},{"id":3327451,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-02T21:01:51.000Z","date":"2019-12-30","kind":"exercise","acquired":false,"shares":1150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the 50,000 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on Nov. 1, 2015."}],"balance_after":48850,"derivative":{"exercise_price":2.46,"exercise_date":"2015-11-01","expiration_date":"2022-01-03","underlying":"Common Stock","underlying_shares":1150},"source":{"system":"sec-edgar","filing":"0001562180-20-000062","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020000062/primarydocument.xml","form_type":"4"}},{"id":3327450,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":146805,"kind":"person","name":"Sanders Dale","position":1,"cik":"0001780970","reported_name":"Sanders Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-01-02T21:01:51.000Z","date":"2019-12-30","kind":"exercise","acquired":true,"shares":1150,"price":2.46,"value":2829.0,"ownership":{"direct":true},"balance_after":61228,"source":{"system":"sec-edgar","filing":"0001562180-20-000062","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780970/000156218020000062/primarydocument.xml","form_type":"4"}}]}